Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes

OBJECTIVE: The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) account for up to 60% of postprandial insulin release in healthy people. Previous studies showed a reduced incretin effect in patients with type 2 diabetes but a robust response to exogeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi, Marzieh, Aulinger, Benedict, Prigeon, Ronald L., D'Alessio, David A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874693/
https://www.ncbi.nlm.nih.gov/pubmed/20215429
http://dx.doi.org/10.2337/db09-1253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874693/
https://www.ncbi.nlm.nih.gov/pubmed/20215429
http://dx.doi.org/10.2337/db09-1253

Ejemplares similares